Balasa Dinverno & Foltz’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$581K Buy
9,426
+3,308
+54% +$204K 0.04% 183
2022
Q2
$378K Sell
6,118
-686
-10% -$42.4K 0.02% 235
2022
Q1
$404K Sell
6,804
-4,069
-37% -$242K 0.03% 222
2021
Q4
$789K Buy
10,873
+2,641
+32% +$192K 0.05% 155
2021
Q3
$575K Buy
8,232
+25
+0.3% +$1.75K 0.04% 180
2021
Q2
$565K Sell
8,207
-1,917
-19% -$132K 0.04% 174
2021
Q1
$654K Buy
10,124
+2,615
+35% +$169K 0.05% 152
2020
Q4
$437K Buy
7,509
+720
+11% +$41.9K 0.04% 180
2020
Q3
$429K Sell
6,789
-10,087
-60% -$637K 0.04% 168
2020
Q2
$1.3M Buy
16,876
+4,049
+32% +$311K 0.14% 66
2020
Q1
$959K Buy
12,827
+3,063
+31% +$229K 0.12% 84
2019
Q4
$634K Sell
9,764
-1,068
-10% -$69.3K 0.07% 135
2019
Q3
$687K Sell
10,832
-121
-1% -$7.67K 0.08% 117
2019
Q2
$740K Buy
10,953
+2,708
+33% +$183K 0.09% 110
2019
Q1
$536K Buy
8,245
+848
+11% +$55.1K 0.06% 126
2018
Q4
$463K Sell
7,397
-7,672
-51% -$480K 0.06% 134
2018
Q3
$1.16M Sell
15,069
-878
-6% -$67.8K 0.13% 64
2018
Q2
$1.13M Sell
15,947
-4,894
-23% -$347K 0.16% 59
2018
Q1
$1.57M Sell
20,841
-1,002
-5% -$75.5K 0.24% 40
2017
Q4
$1.57M Sell
21,843
-476
-2% -$34.1K 0.23% 44
2017
Q3
$1.81M Buy
22,319
+3,311
+17% +$268K 0.28% 33
2017
Q2
$1.35M Buy
19,008
+6,698
+54% +$474K 0.22% 40
2017
Q1
$836K Buy
12,310
+2,608
+27% +$177K 0.14% 63
2016
Q4
$695K Sell
9,702
-2,672
-22% -$191K 0.12% 74
2016
Q3
$979K Buy
12,374
+1,167
+10% +$92.3K 0.18% 52
2016
Q2
$935K Buy
11,207
+1,255
+13% +$105K 0.17% 49
2016
Q1
$914K Sell
9,952
-3,329
-25% -$306K 0.16% 44
2015
Q4
$1.34M Buy
13,281
+341
+3% +$34.5K 0.23% 32
2015
Q3
$1.27M Buy
12,940
+544
+4% +$53.4K 0.22% 32
2015
Q2
$1.45M Buy
12,396
+2,476
+25% +$290K 0.24% 28
2015
Q1
$973K Buy
9,920
+262
+3% +$25.7K 0.14% 43
2014
Q4
$910K Buy
9,658
+229
+2% +$21.6K 0.13% 47
2014
Q3
$1M Buy
9,429
+124
+1% +$13.2K 0.15% 41
2014
Q2
$771K Buy
9,305
+337
+4% +$27.9K 0.09% 47
2014
Q1
$635K Buy
8,968
+629
+8% +$44.5K 0.08% 55
2013
Q4
$626K Buy
8,339
+120
+1% +$9.01K 0.09% 52
2013
Q3
$517K Buy
8,219
+160
+2% +$10.1K 0.09% 59
2013
Q2
$413K Buy
+8,059
New +$413K 0.07% 64